Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer
- 20 June 2006
- journal article
- case report
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 38 (5), 427-434
- https://doi.org/10.1002/lsm.20341
Abstract
Background and Objectives Interstitial photodynamic therapy (PDT) is an emerging modality for the treatment of solid organ disease. Our group at the University of Pennsylvania has performed extensive studies that demonstrate the feasibility of interstitial PDT for prostate cancer. Our preclinical and clinical experience is herein detailed. Study Design/Materials and Methods We have treated 16 canines in preclinical studies, and 16 human subjects in a Phase I study, using motexafin lutetium‐mediated PDT for recurrent prostate adenocarcinoma. Dosimetry of light fluence, drug level and oxygen distribution for these patients were performed. Results We demonstrate the safe and comprehensive treatment of the prostate using PDT. However, there is significant variability in the dose distribution and the subsequent tissue necrosis throughout the prostate. Conclusions PDT is an attractive option for the treatment of prostate adenocarcinoma. However, the observed variation in PDT dose distribution translates into uncertain therapeutic reproducibility. Our future focus will be on the development of an integrated system that is able to both detect and compensate for dose variations in real‐time, in order to deliver a consistent overall PDT dose distribution. Lasers Surg. Med. 38:427–434, 2006.Keywords
This publication has 54 references indexed in Scilit:
- Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶Photochemistry and Photobiology, 2007
- Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic EfficacyClinical Cancer Research, 2005
- Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium–mediated Photodynamic Therapy¶Photochemistry and Photobiology, 2005
- Photodynamic Therapy of Prostate Cancer by Means of 5-Aminolevulinic Acid-Induced Protoporphyrin IX – In vivo Experiments on the Dunning Rat Tumor ModelUrologia Internationalis, 2004
- The Efficacy and Complications of Salvage Cryotherapy of the ProstateJournal of Urology, 1997
- Changes in In Vivo Optical Properties and Light Distributions in Normal Canine Prostate during Photodynamic TherapyRadiation Research, 1997
- Photodosimetry of interstitial light delivery to solid tumorsMedical Physics, 1994
- Optical dosimetry for interstitial photodynamic therapyMedical Physics, 1989
- PHOTOINACTIVATION OF CHINESE HAMSTER CELLS BY HEMATOPORPHYRIN DERIVATIVE AND RED LIGHTPhotochemistry and Photobiology, 1980